Introduction
Globally, researchers are trying to synthesize new drugs with better pharmacokinetic and pharmacodynamic properties with fewer adverse effects. In the recent decades due to rapid development in drug resistance, tolerance and side effects, there is a need for the evolution of a new generation of antimicrobial agents that exhibit improved pharmacological properties and drug-resistance profile. Recently, a number of clinical reports indicated that the multi-drug resistant microorganisms have reached an alarming level in many countries around the globe. Infections caused by these microorganisms pose a serious challenge to the medical community and the need for an effective therapy has led to the search for novel antimicrobial agents [1] [2] [3] . In this aspect, substituted s-triazine, sulfonamide and piperidine derivatives have received attention due to their significant antimicrobial [4] , antibacterial [5] , antifungal [6] , anti-HIV [7] , anticancer [8] , anti-tubercular [9] , antitumor [10] , antiinflammatory [11] and other biological activities [12, 13] .
1,3,5-Triazines represent a widely used lead structure with interesting applications in numerous fields [14, 15] . Several specific synthetic protocols were developed for the preparation of a range of mono, di-and tri-substituted 1,3,5-triazines [16] . 2,4,6-trichloro-1,3,5-triazine i.e. cyanuric chloride is an important, inexpensive starting material due to higher reactivity toward nucleophiles [17, 18] . Piperidine moiety is a very important pharmacophore because of its presence in numerous alkaloids, pharmaceuticals and diverse applications in medicinal area [19] . This heterocyclic moiety is found in drugs like paroxetine, risperidone, methylphenidate, raloxifene, minoxidil and thioridazine. Biologically active alkaloids containing substituted piperidine ring systems have been targeted by medicinal chemists, for their complete or partial synthesis [20] . Sulfonamides having the -NH-SO 2 -group are known to exhibit a broad range of biological activities such as antimicrobial [21] , antimalarial, antileprotic [22] , diuretic, hypoglycemic and anti-thyroid [23] .
Our research group previously reported synthesis, characterization and antimicrobial evaluation of N'-(4-(arylamino)-6-(thiazol-2-ylamino)-1,3,5-triazin-2-yl)isonicotinohydrazide derivatives [24] and 4-(4-(2-isonicotinoylhydrazinyl)-6-((aryl)amino)-1,3,5-triazin-2-ylamino)-N-(pyrimidin-2-yl) benzenesulfonamides [25] . In continuation to this, to design novel antimicrobial agents, we developed a new hypothesis to incorporate benzenesulfonamide, piperidine and s-triazine scaffolds in one framework.
Experimental part

Materials and physical measurements
The completion of reaction and purity of compounds were checked on aluminum coated TLC plates 60 F 245 (E. Merck) using n-hexane: ethyl acetate (7.5: 2.5 V/V) as mobile phase and visualized under ultraviolet (UV) light or in an iodine chamber. Melting points were determined on an electro thermal melting point apparatus and were reported uncorrected. Elemental analysis (% C, H, N) was carried out by a Perkin-Elmer 2400 CHN analyzer. IR spectra of all the compounds were recorded on a Perkin-Elmer FT-IR spectrophotometer using KBr. 1 H NMR (400 MHz) and 13 C NMR (100 MHz) spectra were recorded on a Bruker spectrometer using DMSO-d 6 as solvent and TMS as an internal standard. Mass spectra were obtained on a SHIMADZU LC-MS 2010 spectrometer.
Chemistry
The chlorine atoms of 2,4,6-trichloro-s-triazine exhibit temperature dependent reactivity in the presence of NaOH (hydrochloride acceptor). There is stepwise nucleophilic displacement of three chlorine atoms by various aromatic amines. This leads to the synthesis of trisubstituted 1,3,5-triazines according to the reported procedure [26] .
In the first step, nucleophilic substitution reaction on cyanuric chloride in acetone with 4-amino-N-(pyrimidin-2-yl)benzenesulfonamide at 0-5°C temperature in the presence of 4% NaOH, provided vital and efficient intermediate (1) by neutralization of reaction mixture with dil. HCl i.e. 4-(4,6-dichloro-1, 
4-(4-
Subsequently reaction of 4-(4,6-dichloro-1,3,5-triazine-2-ylamino)-N-(pyrimidin-2-yl)benezenesulfonamide with piperidine at room temperature in the presence of 4% NaOH, followed by neutralization with dil. HCl yielded intermediate 
Where, R= 
(1C, -SO
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Antibacterial assay
The antibacterial assay of synthesized compounds was carried out by preparing serial dilution of given solution using the Mueller Hinton Broth dilution method (Becton Dickinson, USA) [27] , Desai [28] [29] . The standard strains used for antimicrobial activity were procured from the Institute of Microbial Technology, Chandigarh. The compounds (3a-o) were screened for their antibacterial activity in triplicate sets against these bacteria at different concentrations of 1000, 500, 250 and 200 lg/mL. The drugs which were found to be active in primary screening were further diluted to obtain 100, 50 and 25 lg/ mL concentrations. 10 lg/mL suspensions were further inoculated on appropriate media and growth was noted after 24 and 48 h. The lowest concentration, which showed no growth after spot subculture was considered as MIC for each drug. The highest dilution showing at least 99% inhibition was taken as minimum inhibitory concentration (MIC). The test mixture should contain 10 8 cells/mL. The standard drug used in this study was ampicillin for evaluating antibacterial activity which showed (100, 100, 250 and 100 lg/mL) MIC against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Staphylococcus pyogenes respectively.
Antifungal assay
Compounds (3a-o) were tested for antifungal activity in triplicate sets against Candida albicans, Aspergillus niger and Aspergillus clavatus at various concentrations of 1000, 500, 250, 200 and 100 lg/mL and the obtained results were recorded in the form of primary and secondary screening. The compounds which were found to be active in this primary screening were further tested in a second set of dilution against all microorganisms. The lowest concentration, which showed no growth after spot subculture was considered as MIC for each drug. The highest dilution showing at least 99% inhibition was taken as MIC. The test mixture should contain 10 8 spores/mL MIC. Griseofulvin was used as a standard drug for antifungal activity, which showed (500, 100 and 100 lg/mL) MIC against C. albicans, A. niger and A. clavatus respectively.
Antimicrobial activity
The synthesized compounds were evaluated against Gram Table 1 along with the MIC values of reference compounds ampicillin (for bacteria) and griseofulvin (for fungi). The results revealed that majority of synthesized compounds exhibited varying degrees of inhibition against the tested panel of species. The antimicrobial activity of tested compounds can be correlated to structural variations and modifications of the respective compounds. From antimicrobial activity data (Table 1) , it was observed that compounds 3c (-4-Cl), 3n (-4-NO 2 ) and 3o (-4-COOC 2 H 5 ) showed excellent activity against E. coli at MIC 25 lg/mL. Compound 3e (-3-Cl, -4-F) demonstrated very good activity against E.coli at MIC 50 lg/mL. Compounds 3b (-3-Cl), 3d (-2,6-(Cl) 2 ), 3j (-4-CF 3 ), 3k (-4-OCH 3 ) and 3m (-4-OC 2 H 5 ) exhibited good activity against E. coli at MIC 100 lg/ mL. Among the synthesized compounds, 3o (-4-COOC 2 H 5 ) was found to be most potent compared to standard drug at MIC 25 lg/mL against P. aeruginosa. Compounds 3b (-3-Cl), 3d (-2,6-(Cl) 2 ) and 3n (-4-NO 2 ) exhibited very good activity against P. aeruginosa at MIC 50 lg/mL, while compounds 3a (-H), 3c (-4-Cl), 3e (3-Cl, -4-F) and 3i (-3-Cl, -2CH 3 ) furnished good activity against P. aeruginosa at MIC 100 lg/mL. Compounds 3a (-H), 3b (-3-Cl), 3e (-3-Cl, -4-F), 3m (-4-OC 2 H 5 ), 3n (-4-NO 2 ) and 3o (-4-COOC 2 H 5 ) showed very good activity against S. aureus at MIC 100 lg/mL. Compounds 3c (-4-Cl), 3d (-2,6-(Cl) 2 ) and 3f (-2-CH 3 ) displayed good activity against S. aureus at MIC 200 lg/mL and compounds 3g (-4-CH 3 ), 3h (-2,4-(CH 3 ) 2 ) and 3k (-4-OCH 3 ) exhibited moderate activity against S. aureus at MIC 250 lg/mL. Compounds 3a (-H) possessed highest inhibition against S. pyogenes at MIC 50 lg/mL and compounds 3c (-4-Cl), 3d (-2,6-(Cl) 2 ), 3j (-4-CF 3 ), 3m (-4-OC 2 H 5 ), 3n (-4-NO 2 ) and 3o (-4-COOC 2 H 5 ) demonstrated good activity against S. pyogenes at MIC 100 lg/mL. Compounds 3b (-3-Cl), 3f (-2-CH 3 ), 3g (-4-CH 3 ) and 3i (-3-Cl, -2-CH 3 ) revealed very good activity against C. albicans at MIC 250 lg/mL and compounds 3c (-4-Cl), 3d (-2,6-(Cl) 2 ), 3e (-3-Cl, -4-F), 3h (-2,4-(CH 3 ) 2 ) and 3m (-4-OC 2 H 5 ) furnished moderate activity against C. albicans at MIC 500 lg/mL.
Result and discussion
The characterization of newly synthesized compounds of the series (3a-o) was accomplished by IR, 1 H NMR, 13 C NMR and Mass spectral analysis. Titled compound (3a) possesses three motif benzenesulfonamide, piperidine and 1,3,5-triazine. From IR spectra, 2°amines (i.e. -NH-) directly attached to the triazine ring indicated strong absorption band at 3342 cm À1 . The absorption due to C‚N stretching in pyrimidine and s-triazine rings appeared at 1626 cm À1 . The presence of C-N stretching in pyrimidine, triazine and piperidine rings was demonstrated by intense absorption at 1285 cm À1 . Due to S‚O stretching in benzenesulfonamide, a medium intensity absorption band was observed at 1170 cm
À1
. In 1 H NMR spectra of the title compound (3a), two Ar-NH-triazine protons appeared as a singlet at d = 6.58 ppm whereas one proton of -NH-SO 2 
Structure activity relationship (SAR)
The substitution pattern of s-triazine derivatives was carefully selected to confer different electronic environments to the molecules. The results from antimicrobial activity suggested that s-triazine derivatives were remarkably influenced by var- ious substituents on the phenyl ring. Some of the synthesized compounds of this series exhibited significant antibacterial and moderate antifungal activities. The bioassay results demonstrated that some analogs were very active at MIC values 25-50 lg/mL. Among the synthesized compounds, 3c (-4-Cl), 3n (-4-NO 2 ) and 3o (-COOC 2 H 5 ) exhibited highest inhibition against bacterial strains E. coli at MIC 25 lg/mL. Furthermore, compound 3n showed significant inhibition against P. aeruginosa at MIC 25 lg/mL and compound 3o exhibited significant activity against P. aeruginosa at MIC 25 lg/mL. The data revealed that replacement of hydrogen on the phenyl ring of the targeted compound (3a) from para position with electron withdrawing groups like halogen, nitro and ester remarkably enhanced the antimicrobial activity against selected microorganisms. Thus, our aim was to explore SAR of synthesized compounds and to develop lead molecules for further optimization.
Conclusion
The interest of organic chemists in 2,4,6-trichloro-1,3,5-triazine as a starting material is due to the temperature dependent reactivity of three chlorine atoms that allow a sequential introduction of various substituents. In the present article, we have reported the synthesis, characterization and antimicrobial activity of some novel s-triazine based piperidine and benzenesulfonamide derivatives. Out of the fifteen compounds, 3c, 3n and 3o exhibited significant antimicrobial activity on several strains of microbes. It is worth mentioning that insertion of various electron withdrawing groups enhanced the pharmacological activities of the resultant scaffolds by lowering the MIC values. It may be concluded that electron withdrawing substituents on the phenyl ring are most suitable for the present scaffold to achieve optimum antimicrobial spectrum. In short, the present study can lead medicinal chemists to design and synthesize similar compounds with enhanced biological potency in future.
